These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21537170)

  • 1. Implementing operational research to scale-up access to antiretroviral therapy for HIV infection: lessons learned from the Cameroonian experience.
    Boyer S; Koulla-Shiro S; Abé C; Spire B; Moatti JP
    Curr Opin HIV AIDS; 2011 Jul; 6(4):239-44. PubMed ID: 21537170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research as a path to wide-scale implementation of antiretroviral therapy in Africa.
    Sanne I; van der Horst C
    J HIV Ther; 2004 Sep; 9(3):65-8. PubMed ID: 15534564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon.
    Boyer S; Eboko F; Camara M; Abé C; Nguini ME; Koulla-Shiro S; Moatti JP
    AIDS; 2010 Jan; 24 Suppl 1():S5-15. PubMed ID: 20023440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term immunological outcomes in treated HIV-infected individuals in high-income and low-middle income countries.
    Achhra AC; Phanuphak P; Amin J
    Curr Opin HIV AIDS; 2011 Jul; 6(4):258-65. PubMed ID: 21546834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community health outreach program of the Chad-Cameroon petroleum development and pipeline project.
    Utzinger J; Wyss K; Moto DD; Tanner M; Singer BH
    Clin Occup Environ Med; 2004 Feb; 4(1):9-26. PubMed ID: 15043361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges to the success of HIV and tuberculosis care and treatment in the public health sector in South Africa.
    Dong K; Thabethe Z; Hurtado R; Sibaya T; Dlwati H; Walker B; Wilson D
    J Infect Dis; 2007 Dec; 196 Suppl 3():S491-6. PubMed ID: 18181699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future management of treatment failure in low- and middle-income countries.
    Boyd MA
    Curr Opin HIV AIDS; 2010 Jan; 5(1):83-9. PubMed ID: 20046152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operational research and HIV policy and guidelines: lessons from a study of patients lost to follow-up from a public antiretroviral treatment program in Cameroon.
    Mben JM; Kouanfack C; Essomba CN; Mbougua JB; Kenfack A; Tonfack CA; Laborde-Balen G; Bourgeois A; Biwolé-Sida M; Delaporte E; Laurent C
    J Public Health Policy; 2012 Nov; 33(4):462-77. PubMed ID: 22932024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equity and efficiency in scaling up access to HIV-related interventions in resource-limited settings.
    Cleary S
    Curr Opin HIV AIDS; 2010 May; 5(3):210-4. PubMed ID: 20539076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involving new actors to achieve ART scaling-up: difficulties in an HIV/AIDS counselling and testing centre in Cameroon.
    Yakam JC; Gruénais ME
    Int Nurs Rev; 2009 Mar; 56(1):50-7. PubMed ID: 19239516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing HIV treatment programs.
    Bautista-Arredondo S; Martz TE; Wirtz VJ; Bertozzi SM
    Curr Opin HIV AIDS; 2010 May; 5(3):232-6. PubMed ID: 20539079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-class HIV antiretroviral therapy failure in an Australian primary care setting.
    Bloch M; Farris M; Tilden D; Gowers A; Cunningham N
    Sex Health; 2010 Mar; 7(1):17-24. PubMed ID: 20152091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs associated with combination antiretroviral therapy in HIV-infected patients.
    Yazdanpanah Y
    J Antimicrob Chemother; 2004 Apr; 53(4):558-61. PubMed ID: 14985277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivering comprehensive home-based care programmes for HIV: a review of lessons learned and challenges ahead in the era of antiretroviral therapy.
    Wringe A; Cataldo F; Stevenson N; Fakoya A
    Health Policy Plan; 2010 Sep; 25(5):352-62. PubMed ID: 20144935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy for children in the routine setting in Malawi.
    Malawi Paediatric Antiretroviral Treatment Group
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):511-6. PubMed ID: 17197006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of antiretroviral therapy coverage: methodology and trends.
    Mahy M; Tassie JM; Ghys PD; Stover J; Beusenberg M; Akwara P; Souteyrand Y
    Curr Opin HIV AIDS; 2010 Jan; 5(1):97-102. PubMed ID: 20046154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements in antiretroviral therapy outcomes over calendar time.
    Boyd MA
    Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.